“Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions”. Current Pharmaceutical Research, vol. 1, no. 3, Oct. 2025, pp. 308-22, https://doi.org/10.63785/cpr.2025.1.3.308322.